A detailed history of Signaturefd, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 158 shares of ARDX stock, worth $813. This represents 0.0% of its overall portfolio holdings.

Number of Shares
158
Previous 757 79.13%
Holding current value
$813
Previous $5,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$5.28 - $7.57 $3,162 - $4,534
-599 Reduced 79.13%
158 $1,000
Q2 2024

Jul 29, 2024

BUY
$5.89 - $9.31 $3,528 - $5,576
599 Added 379.11%
757 $5,000
Q4 2023

Jan 31, 2024

BUY
$3.29 - $6.64 $213 - $431
65 Added 69.89%
158 $0
Q3 2023

Nov 03, 2023

SELL
$3.3 - $4.83 $376 - $550
-114 Reduced 55.07%
93 $0
Q2 2023

Aug 01, 2023

BUY
$3.23 - $4.95 $368 - $564
114 Added 122.58%
207 $0
Q4 2022

Jan 27, 2023

BUY
$1.22 - $2.85 $113 - $265
93 New
93 $0

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $796M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.